Photo 1 sur 1
Biotechnologie Pharmaceutique par Carlos A Guzman : Neuf
État :
Expédition :
Lieu : Lee's Summit, Missouri, États-Unis
Livraison :
Livraison prévue entre le ven. 31 mai et le mer. 5 juin à 43230
Renvois :
Paiements :
Magasinez en toute confiance
Informations sur le vendeur
Le vendeur assume l'entière responsabilité de cette annonce.
Numéro de l'objet eBay :163697423828
Dernière mise à jour : mai 19, 2021 18:13:47 HAEAfficher toutes les modificationsAfficher toutes les modifications
Caractéristiques de l'objet
- État
- Publisher
- Springer New York
- Publication Date
- 2009-08-01
- Pages
- 256
- ISBN
- 9781441911315
- EAN
- 9781441911315
- Series
- Advances in Experimental Medicine and Biology Ser.
- Publication Year
- 2009
- Type
- Textbook
- Format
- Hardcover
- Language
- English
- Publication Name
- Pharmaceutical Biotechnology
- Item Length
- 9.3in
- Item Width
- 6.1in
- Item Weight
- 21 Oz
- Number of Pages
- 276 Pages
À propos de ce produit
Product Information
Pharmaceutical Biotechnology is a unique compilation of reviews addressing frontiers in biologicals as a rich source for innovative medicines. This book fulfills the needs of a broad community of scientists interested in biologicals from diverse perspectives--basic research, biotechnology, protein engineering, protein delivery, medicines, pharmaceuticals and vaccinology. The diverse topics range from advanced biotechnologies aimed to introduce novel, potent engineered vaccines of unprecedented efficacy and safety for a wide scope of human diseases to natural products, small peptides and polypeptides engineered for discrete prophylaxis and therapeutic purposes. Modern biologicals promise to dramatically expand the scope of preventive medicine beyond the infectious disease arena into broad applications in immune and cancer treatment, as exemplified by anti-EGFR receptors antibodies for the treatment of breast cancer. The exponential growth in biologicals such as engineered proteins andvaccines has been boosted by unprecedented scientific breakthroughs made in the past decades culminating in an in-depth fundamental understanding of the scientific underpinnings of immune mechanisms together with knowledge of protein and peptide scaffolds that can be deliberately manipulated. This has in turn led to new strategies and processes. Deciphering the human, mammalian and numerous pathogens' genomes provides opportunities that never before have been available--identification of discrete antigens (genomes and antigenomes) that lend themselves to considerably improved antigens and monoclonal antibodies, which with more sophisticated engineered adjuvants and agonists of pattern recognition receptors present in immune cells, deliver unprecedented safety and efficacy. Technological development such a nanobiotechnologies (dendrimers, nanobodies and fullerenes), biological particles (viral-like particles and bacterial ghosts) and innovative vectors (replication-competent attenuated,replication-incompetent recombinant and defective helper-dependent vectors) fulfill a broad range of cutting-edge research, drug discovery and delivery applications. Most recent examples of breakthrough biologicals include the human papilloma virus vaccine (HPV, prevention of women genital cancer) and the multivalent Pneumoccocal vaccines, which has virtually eradicated in some populations a most prevalent bacterial ear infection (i.e., otitis media). It is expected that in the years to come similar success will be obtained in the development of vaccines for diseases which still represent major threats for human health, such as AIDS, as well as for the generation of improved vaccines against diseases like pandemic flu for which vaccines are currently available. Furthermore, advances in comparative immunology and innate immunity revealed opportunities for innovative strategies for ever smaller biologicals and vaccines derived from species such as llama and sharks, which carry tremendous potential for innovative biologicals already in development stages in many pharmaceutical companies. Such recent discoveries and knowledge exploitations hold the promise for breakthrough biologicals, with the coming decade. Finally, this book caters to individuals not directly engaged in the pharmaceutical drug discovery process via a chapter outlining discovery, preclinical development, clinical development and translational medicine issues that are critical the drug development process. The authors and editors hope that this compilation of reviews will help readers rapidly and completely update knowledge and understanding of the frontiers in pharmaceutical biotechnologies.
Product Identifiers
Publisher
Springer New York
ISBN-10
1441911316
ISBN-13
9781441911315
eBay Product ID (ePID)
109297780
Product Key Features
Publication Name
Pharmaceutical Biotechnology
Format
Hardcover
Language
English
Series
Advances in Experimental Medicine and Biology Ser.
Publication Year
2009
Type
Textbook
Number of Pages
276 Pages
Dimensions
Item Length
9.3in
Item Width
6.1in
Item Weight
21 Oz
Additional Product Features
Series Volume Number
655
Number of Volumes
1 Vol.
Lc Classification Number
Rs400-431
Table of Content
Translational Medicine--A Paradigm Shift in Modern Drug Discovery and Development: The Role of Biomarkers.- Natural Products in Drug Discovery: Present Status and Perspectives.- Protein Pharmaceuticals: Discovery and Preclinical Development.- The Role of Nanobiotechnology in Drug Discovery.- Conotoxin Venom Peptide Therapeutics.- Shark Novel Antigen Receptors--The Next Generation of Biologic Therapeutics?.- Immune Interventions of Human Diseases through Toll-Like Receptors.- Genome-Based Vaccine Development: A Short Cut for the Future.- The Antigenome: From Protein Subunit Vaccines to Antibody Treatments of Bacterial Infections?.- HSV as a Vector in Vaccine Development and Gene Therapy.- Virus-Like Particles as a Vaccine Delivery System: Myths and Facts.- Applications of Bacterial Ghosts in Biomedicine.- Immune Modulators with Defined Molecular Targets: Cornerstone to Optimize Rational Vaccine Design.- Innovative Approaches to Develop Prophylactic and Therapeutic Vaccines against HIV/AIDS.- New Strategies to Overcome the Drawbacks of Currently Available Flu Vaccines.
Copyright Date
2009
Topic
Pharmacy, Research, Chemistry / Organic
Lccn
2009-024877
Dewey Decimal
615/.19
Intended Audience
Scholarly & Professional
Dewey Edition
22
Illustrated
Yes
Genre
Science, Medical
Description de l'objet du vendeur
Le vendeur assume l'entière responsabilité de cette annonce.
Numéro de l'objet eBay :163697423828
Dernière mise à jour : mai 19, 2021 18:13:47 HAEAfficher toutes les modificationsAfficher toutes les modifications
Expédition et manutention
Lieu où se trouve l'objet :
Lee's Summit, Missouri, États-Unis
Expédition :
Afghanistan, Afrique du Sud, Albanie, Algérie, Allemagne, Andorre, Angola, Anguilla, Antigua-et-Barbuda, Arabie saoudite, Argentine, Arménie, Aruba, Australie, Autriche, Azerbaïdjan, Bahamas, Bahreïn, Bangladesh, Belgique, Bermudes, Bhoutan, Bolivie, Bosnie-Herzégovine, Botswana, Brunéi Darussalam, Brésil, Bulgarie, Burkina Faso, Burundi, Bélize, Bénin, Cambodge, Cameroun, Canada, Chili, Chine, Chypre, Colombie, Corée du Sud, Costa Rica, Côte d'Ivoire, Danemark, Djibouti, Espagne, Estonie, Fidji, Finlande, France, Gabon, République du, Gambie, Ghana, Gibraltar, Grenade, Groenland, Grèce, Guatemala, Guinée, Guinée équatoriale, Guinée-Bissau, Guyana, Géorgie, Haïti, Honduras, Hong Kong, Hongrie, Inde, Indonésie, Irlande, Islande, Israël, Italie, Jamaïque, Japon, Jordanie, Kazakhstan, Kenya, Kirghizistan, Kiribati, Koweït, Laos, Lesotho, Lettonie, Liban, Libéria, Liechtenstein, Lituanie, Luxembourg, Macao, Macédoine, Madagascar, Malaisie, Malawi, Maldives, Mali, Malte, Maroc, Mauritanie, Mexique, Moldavie, Monaco, Mongolie, Montserrat, Monténégro, Mozambique, Namibie, Nauru, Nicaragua, Niger, Nigeria, Norvège, Nouvelle-Zélande, Népal, Oman, Ouganda, Ouzbékistan, Pakistan, Panama, Papouasie-Nouvelle-Guinée, Paraguay, Pays-Bas, Philippines, Pologne, Portugal, Pérou, Qatar, Roumanie, Royaume-Uni, Rwanda, République centrafricaine, République de Croatie, République dominicaine, République du Congo, République démocratique du Congo, République tchèque, Saint-Kitts-et-Nevis, Saint-Marin, Saint-Vincent-et-les Grenadines, Sainte-Lucie, Salvador, Samoa, Serbie, Seychelles, Sierra Leone, Singapour, Slovaque, Slovénie, Sri Lanka, Suisse, Suriname, Suède, Swaziland, Sénégal, Tadjikistan, Tanzanie, Taïwan, Tchad, Thaïlande, Togo, Tonga, Trinité-et-Tobago, Tunisie, Turkménistan, Turquie, Uruguay, Vanuatu, Vietnam, Wallis-et-Futuna, Yémen, Zambie, Zimbabwe, Égypte, Émirats arabes unis, Équateur, Érythrée, État de la Cité du Vatican, États-Unis, Éthiopie, Île Maurice, Îles Caïmans, Îles Salomon, Îles Turks et Caicos, Îles du Cap-Vert
Lieux exclus :
Barbade, Guadeloupe, Guyane française, Libye, Martinique, Nouvelle-Calédonie, Polynésie française, Russie, Réunion, Ukraine, Venezuela
Expédition et manutention | À | Service | Livraison*Voir les remarques sur la livraison |
---|---|---|---|
3,99 $US (environ 5,44 $C) | États-Unis | Expédition au tarif économique (USPS Media MailTM) | Livraison prévue entre le ven. 31 mai et le mer. 5 juin à 43230 |
Délai de manutention |
---|
Expédition dans les 3 jours ouvrables après réception du paiement. |
Taxes |
---|
Des taxes peuvent s'appliquer à la conclusion de la transaction. En savoir plusEn savoir plus au sujet du paiement de taxes sur les achats eBay. |
Taxe de vente pour cet objet (163697423828)
Taxe de vente pour cet objet (163697423828)
Le vendeur facture une taxe de vente pour les États suivants :
État | Taux de la taxe de vente |
---|
Modalités de renvoi
Détails sur les modalités de renvoi |
---|
Le vendeur refusera les renvois pour cet objet. |
Détails du paiement
Modes de paiement
Évaluations comme vendeur (4 909)
5***r (18)- Évaluation laissée par l'acheteur.
Dernier mois
Achat vérifié
Wonderfull experience; thank you very much!!
0***c (902)- Évaluation laissée par l'acheteur.
Dernier mois
Achat vérifié
A+++
m***y (1129)- Évaluation laissée par l'acheteur.
Dernier mois
Achat vérifié
A+++